Skip to content Skip to footer
Aminoglutethimide: Benefits, Reviews, Info, Side Effects!
Rx Details
Aminoglutethimide
Cytadren, Orimeten, Aminoglutethimide
Aminoglutethimide
Prescription
Drug
Drugs
Prescription Only
inhibits steroid synthesis, treats Cushing’s syndrome, used in breast cancer therapy, used in prostate cancer therapy, reduces adrenal gland hormone production
Adrenal Insufficiency, Confusion, Depression, Dizziness, Drowsiness, Fatigue, Fever, Headache, Joint Pain, Liver Dysfunction, Loss Of Appetite, Low Blood Pressure, Nausea, Rash, Weakness
Aminoglutethimide is a medication that was historically used to treat certain types of cancers and Cushing’s syndrome by inhibiting steroid production. The typical dosage for aminoglutethimide can vary based on the condition being treated and the individual patient’s needs. However, a common dosage for adults is: – **For Cushing’s syndrome:** The usual starting dose is 250 mg every 6 hours. The dose may be adjusted based on the patient’s response and tolerance. – **For metastatic breast cancer or prostate cancer:** The dosage can also start at 250 mg every 6 hours, but it may be adjusted according to the specific treatment protocol and patient response. It’s important to note that aminoglutethimide is not commonly used today, as newer and more effective treatments have become available. Always consult a healthcare professional for the most appropriate dosage and treatment plan for individual cases.
Cushing’s syndrome, breast cancer, prostate cancer, adrenal cancer
Aminoglutethimide has a favorable safety profile.
Interactions with corticosteroids, warfarin, phenytoin, carbamazepine
$50 – $100
$1,200

A Synopsis of

Aminoglutethimide

Aminoglutethimide is a medication that is primarily used in the treatment of certain types of cancer, specifically breast cancer and Cushing’s syndrome. It works by inhibiting the production of certain hormones in the body, which can help to slow the growth of cancer cells and alleviate symptoms associated with Cushing’s syndrome.

This medication is typically taken orally in the form of a tablet, and the dosage will vary depending on the individual’s condition and response to treatment. It is important to follow your healthcare provider’s instructions carefully when taking aminoglutethimide to ensure its effectiveness and minimize the risk of side effects.

Like all medications, aminoglutethimide can cause side effects in some individuals. Common side effects may include dizziness, drowsiness, nausea, and changes in appetite. It is important to report any unusual or severe side effects to your healthcare provider promptly.

Before starting treatment with aminoglutethimide, it is important to inform your healthcare provider about any other medications or supplements you are taking, as well as any medical conditions you may have. This will help to prevent any potential interactions or complications.

Overall, aminoglutethimide can be an effective treatment option for individuals with certain types of cancer or Cushing’s syndrome. It is important to work closely with your healthcare provider to determine if this medication is right for you and to monitor your progress throughout treatment. If you have any questions or concerns about aminoglutethimide, do not hesitate to discuss them with your healthcare provider.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN